BioView develops and markets innovative automated cell diagnostic systems via fluorescence in-situ hybridization (FISH) for clinical and research laboratories. The Duet™, and ALLEGRO scanning workstations provide automated detection, analysis and reporting of cells of interest, under fluorescence and brightfield microscopy. Bladder Cancer FISH (UroVysion) is among the FDA cleared applications.